Prevention and management of infection after total joint replacement

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
W J Gillespie

Abstract

Prophylactic antimicrobial regimens providing adequate drug levels in tissue during surgery and for periods of 24 hours to 14 days are of proven effectiveness in reducing infection rates after joint arthroplasty. Although most surgeons employ short regimens of < 24 hours' duration, their efficacy has not been clearly established for joint replacement in placebo-controlled trials. Careful preparation of the patient before surgery and attention to operating room asepsis are also important. In early postoperative infections, surgical debridement and antibiotic treatment may allow conservation of the prosthetic components. In established infection in which the components have become loose, radical surgical debridement must include removal of all prosthetic material as well as involved bone and soft tissue; reconstruction by exchange arthroplasty has an acceptable success rate. For infections caused by organisms of low virulence, exchange arthroplasty has been successful as a one-stage procedure, but no comparative trial with two-stage exchange has yet been reported.

Citations

Sep 14, 2002·Current Infectious Disease Reports·Edna Toubes, John Segreti
Apr 19, 2013·Journal of Biomaterials Science. Polymer Edition·Alexia Hernandez-SoriaMathias Bostrom
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D N FismanS J Goldie
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A F Widmer
Jan 20, 2000·Antimicrobial Agents and Chemotherapy·F de LallaP Fabris
Apr 16, 2004·Clinical Microbiology Reviews·Erna M Kojic, Rabih O Darouiche
Feb 20, 2016·Clinical Orthopaedics and Related Research·Bhaveen H KapadiaMichael A Mont
May 4, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J Barberán
Feb 13, 2010·The Journal of Arthroplasty·Mark D EarllRussell S Rougeux
Mar 10, 2016·Clinical Orthopaedics and Related Research·Bhaveen H KapadiaMichael A Mont
Sep 11, 2007·Infectious Disease Clinics of North America·Marta Fernandez Sampedro, Robin Patel
Nov 22, 2005·Infectious Disease Clinics of North America·Irene G SiaAdolf W Karchmer
Jan 5, 2008·Molecular Ecology·Camille LebarbenchonFrédéric Thomas
Nov 22, 2011·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·James D OeiKyumin Whang
May 29, 2014·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Roli KarguptaShramik Sengupta
Jul 25, 2006·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Louis G Mercuri
Apr 9, 2002·Journal of Chemotherapy·F de Lalla
Nov 2, 2012·The Journal of Arthroplasty·Bhaveen H KapadiaMichael A Mont
Aug 30, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L J DayC A Kauffman
Mar 2, 2005·The Journal of Bone and Joint Surgery. British Volume·R TrebseA Trampuz
Jan 28, 2014·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Vinay K AggarwalWilliam Charles Watters
May 2, 2014·Annals of the Royal College of Surgeons of England·K B FergusonA M Bal
Dec 7, 2002·Journal of Orthopaedic Surgery·Myung-Sang Moon, Jeong-Lim Moon
Dec 4, 2004·Clinical Orthopaedics and Related Research·Javad ParviziNoreen J Hickok
Feb 12, 2013·Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy·Jesse W P KuiperDiederik A Vergroesen
Oct 31, 2009·Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy·Radwane FarougMaher Halawa
Apr 12, 2006·Enfermedades infecciosas y microbiología clínica·Javier García-PontUNKNOWN Grupo de Estudio de la Infección de Prótesis
Sep 22, 2021·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Naofumi OhtsuYutaka Yoshida

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Adolf W Karchmer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
P TattevinC Carbon
© 2021 Meta ULC. All rights reserved